Observational studies on the market launch of risk-reduced products
The overall objective of assessing the marketed product is to further substantiate the results collected in the pre-market Clinical Assessment and Perception and Behavioral Assessment Programs, in consumers under real-world conditions. These studies are designed from one source to assess the impact that the marketing of IQOSTM products has on consumer perceptions, behavior, exposures, and health.
ARGUS GmbH supports Philip Morris S.A. in statistical analysis, data management, quality control and clinical trial planning.
Find out more?
If you are interested in observational studies please write to us at firstname.lastname@example.org or simply give us a call. You can reach us Mo to Fr from 9 am to 6 pm under +49 30 398060-0.
More information is available on INTERVALS Sciene Platform.